跳至主要内容
临床试验/NCT04045561
NCT04045561已完成不适用

Elaboration of a Standardized Referential Guide of the Information to Optimize the Adherence to be Given During an Initial Pharmaceutical Consultation (CP) to the Patient Suffering From Multiple Myeloma in Primocure Chemotherapy Per os

Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2015年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
evaluating the understanding

研究概览

简要总结

The hypothesis is that the implementation of an initial Pharmaceutical Consultation (PC) program based on the provision of standardized information to patients treated for multiple myeloma as a first course of chemotherapy, could optimize their compliance with the delivered per os treatment.

The aim of this study is therefore to develop a standardised reference guide of information to be provided during prostate cancer in order to optimise the compliance of patients treated for multiple myeloma as a first course of chemotherapy per os.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The patient must be a member or beneficiary of a health insurance plan
  • •The patient is at least 18 years old
  • •The patient is treated for multiple myeloma, is naive to any treatment and begins a chemotherapy protocol with oral therapy and whose course of care includes a stay in the Day Hospital or retrocessions.
  • •Criteria for non-inclusion
  • •The subject is participating in another study
  • •The subject is in an exclusion period determined by a previous study
  • •The subject is under the protection of justice, guardianship or curatorship
  • •It is impossible to give informed information about
  • •The patient is pregnant, parturient, or breastfeeding
  • •The patient receives a follow-up by a home nurse for the administration of oral medication
  • •The patient is treated only with oral chemotherapy in the city
  • •The patient has early dementia.
  • •Translated with www.DeepL.com/Translator

排除标准

  • 未提供

结局指标

主要结局

evaluating the understanding

时间窗: Day 1

Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution.

evaluating understanding

时间窗: Day 1

Questionnaire. qualitative variables: measurement of their number and

evaluating the quality of information

时间窗: Day 1

Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution.

evaluating quality of information

时间窗: Day 1

Questionnaire. qualitative variables: measurement of their number and percentage.

次要结局

  • The time required for the pharmaceutical consultation(Day 1)
  • satisfaction des patients(Day 1)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验